These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32139710)

  • 1. Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.
    Roy S; Kumar R; Mittal V; Gupta D
    Sci Rep; 2020 Mar; 10(1):4113. PubMed ID: 32139710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture.
    Kishore A; Venkataramana L; Prasad DVV; Mohan A; Jha B
    Med Biol Eng Comput; 2023 Nov; 61(11):2895-2919. PubMed ID: 37530887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and transfer of spatial transcriptomics signatures for cancer diagnosis.
    Yoosuf N; Navarro JF; Salmén F; Ståhl PL; Daub CO
    Breast Cancer Res; 2020 Jan; 22(1):6. PubMed ID: 31931856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between ADAMTS8, ADAMTS18, and ADAMTS20 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) Expressions and Tumor Molecular Classification, Clinical Pathological Parameters, and Prognosis in Breast Invasive Ductal Carcinoma.
    Guo X; Li J; Zhang H; Liu H; Liu Z; Wei X
    Med Sci Monit; 2018 Jun; 24():3726-3735. PubMed ID: 29860265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development.
    Aswad L; Yenamandra SP; Ow GS; Grinchuk O; Ivshina AV; Kuznetsov VA
    Oncotarget; 2015 Nov; 6(34):36652-74. PubMed ID: 26474389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
    Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
    Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
    Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning models to predict the progression from early to late stages of papillary renal cell carcinoma.
    Singh NP; Bapi RS; Vinod PK
    Comput Biol Med; 2018 Sep; 100():92-99. PubMed ID: 29990647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
    Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated meta-analysis and machine learning approach identifies acyl-CoA thioesterase with other novel genes responsible for biofilm development in Staphylococcus aureus.
    Subramanian D; Natarajan J
    Infect Genet Evol; 2021 Mar; 88():104702. PubMed ID: 33388440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNN-based deep learning approach for classification of invasive ductal and metastasis types of breast carcinoma.
    Islam T; Hoque ME; Ullah M; Islam T; Nishu NA; Islam R
    Cancer Med; 2024 Aug; 13(16):e70069. PubMed ID: 39215495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.
    Zhao Y; Wang Y; Zhu F; Zhang J; Ma X; Zhang D
    Clin Exp Med; 2020 May; 20(2):249-259. PubMed ID: 31980982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refinement of breast cancer classification by molecular characterization of histological special types.
    Weigelt B; Horlings HM; Kreike B; Hayes MM; Hauptmann M; Wessels LF; de Jong D; Van de Vijver MJ; Van't Veer LJ; Peterse JL
    J Pathol; 2008 Oct; 216(2):141-50. PubMed ID: 18720457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Machine Learning Methods to Predict Bone Metastases in Breast Infiltrating Ductal Carcinoma Patients.
    Liu WC; Li MX; Wu SN; Tong WL; Li AA; Sun BL; Liu ZL; Liu JM
    Front Public Health; 2022; 10():922510. PubMed ID: 35875050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning for RNA sequencing-based intrinsic subtyping of breast cancer.
    Cascianelli S; Molineris I; Isella C; Masseroli M; Medico E
    Sci Rep; 2020 Aug; 10(1):14071. PubMed ID: 32826944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
    Chen S; Wang J; Yang L; Ji M; Chen S
    J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.